Pendal Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$465K Buy
2019
Q4
Sell
2019
Q3
$770K Sell
2019
Q2
$1.06M Buy
2019
Q1
$1.04M Hold
2018
Q4
$999K Sell
2018
Q3
$1.14M Hold
2018
Q2
$1.11M Sell
2018
Q1
$952K Buy
2017
Q4
$1.03M Buy
2017
Q3
$1.03M Buy
2017
Q2
$600K Buy